These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7895425

  • 1. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation.
    Lazarovits AI, Tibbles LA, Grant DR, Ghent CN, Wall WJ, White MJ, Joncas JH.
    Clin Invest Med; 1994 Dec; 17(6):621-5. PubMed ID: 7895425
    [Abstract] [Full Text] [Related]

  • 2. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B, Kropshofer G, Ellemunter H, Brunner A, Mueller T, Margreiter R, Tzankov A.
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [Abstract] [Full Text] [Related]

  • 3. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
    Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C.
    N Engl J Med; 1991 May 23; 324(21):1451-6. PubMed ID: 2023604
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation.
    Garnier JL, Berger F, Betuel H, Vuillaume M, Chapuis-Cellier C, Blanc N, Faure JL, Dubernard JM, Lenoir G, Touraine JL.
    Nephrol Dial Transplant; 1989 May 23; 4(9):818-23. PubMed ID: 2560533
    [Abstract] [Full Text] [Related]

  • 5. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 23; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 6. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May 23; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 7. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 8. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.
    J Med Virol; 2008 Mar 15; 80(3):441-54. PubMed ID: 18205222
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK.
    Liver Transpl Surg; 1995 Sep 15; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract] [Full Text] [Related]

  • 11. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 15; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.
    Zettl A, Lee SS, Rüdiger T, Starostik P, Marino M, Kirchner T, Ott M, Müller-Hermelink HK, Ott G.
    Am J Clin Pathol; 2002 Mar 15; 117(3):368-79. PubMed ID: 11888076
    [Abstract] [Full Text] [Related]

  • 15. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L, Linde A, Falk KI.
    Transpl Int; 2005 Jul 15; 18(7):835-43. PubMed ID: 15948864
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A, Spieker T, Mottok A, Baur AS, Küppers R, Hansmann ML.
    Eur J Immunol; 2003 Jun 15; 33(6):1593-602. PubMed ID: 12778477
    [Abstract] [Full Text] [Related]

  • 17. Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: report of three cases.
    Codeluppi M, Cocchi S, Guaraldi G, Di Benedetto F, Bagni A, Pecorari M, Gennari W, Pinna AD, Gerunda GE, Esposito R.
    Transplant Proc; 2005 Jun 15; 37(6):2634-5. PubMed ID: 16182770
    [Abstract] [Full Text] [Related]

  • 18. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE.
    Mod Pathol; 1996 Jun 15; 9(6):621-30. PubMed ID: 8782198
    [Abstract] [Full Text] [Related]

  • 19. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
    Garceau P, Couture C, Cantin B, Bernier V, Sénéchal M.
    J Heart Lung Transplant; 2008 Aug 20; 27(8):928-31. PubMed ID: 18656811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.